{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T17:55:02Z","timestamp":1726163702534},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/s0959-8049(03)00660-9","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T06:52:31Z","timestamp":1065855151000},"page":"198-204","source":"Crossref","is-referenced-by-count":13,"title":["Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients"],"prefix":"10.1016","volume":"40","author":[{"given":"P.B","family":"Ottevanger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.M","family":"De Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.T.M","family":"Grol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"van Lier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.V.A.M","family":"Beex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(03)00660-9_BIB1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice","volume":"342","author":"Grimshaw","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB2","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(05)60393-5","article-title":"Development of clinical guidelines","volume":"352","author":"Fletcher","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0029-7844(97)00008-2","article-title":"An outcomes management program in gynecologic oncology","volume":"89","author":"Morris","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0959-8049(98)00376-1","article-title":"Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre study. The Breast Cancer Group of the Dutch Comprehensive Cancer Centre East (IKO)","volume":"35","author":"Ottevanger","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB5","first-page":"459","article-title":"Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice","volume":"22","author":"Ottevanger","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM198101013040103","article-title":"Dose-response effect of adjuvant chemotherapy in breast cancer","volume":"304","author":"Bonadonna","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node- positive breast cancer","volume":"332","author":"Bonadonna","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199405053301801","article-title":"Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma","volume":"330","author":"Wood","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM199605233342102","article-title":"The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer","volume":"334","author":"Recht","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jama.281.8.720","article-title":"Stage at diagnosis and treatment patterns among older women with breast cancer","volume":"281","author":"Riley","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ijc.1408","article-title":"Differences in stage and therapy for breast cancer across Europe","volume":"93","author":"Sant","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB13","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 Update of Recommendations for the use of hematopoietic colony-stimulating factors","volume":"18","author":"Ozer","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00660-9_BIB14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005650-199403000-00002","article-title":"Evaluating the message","volume":"32","author":"Grilli","year":"1994","journal-title":"Med. Care"},{"key":"10.1016\/S0959-8049(03)00660-9_BIB15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.317.7162.858","article-title":"Attributes of clinical guidelines that influence use of guidelines in general practice","volume":"317","author":"Grol","year":"1998","journal-title":"Br Med J"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903006609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903006609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:59:26Z","timestamp":1550699966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804903006609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0959804903006609"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(03)00660-9","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}